StockData
American Vanguard Corp logo

American Vanguard Corp (AVD) stock analysis

AVDNYSEAgricultural ChemicalsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 3/30
$0.88+0.06 (+7.46%)

Close on Nov 11, 2026Market cap $25.09MP/E –Yield –

StockData Score

Prices as of Nov 11, 2026How the score works

Value1Growth1Performance0Health1Dividend0

Weak3 of 30 checks passed

American Vanguard passes 3 of the 30 checks behind our score; 19 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
1/6
Growth
1/6
Past performance
0/6
Financial health
1/6
Dividend
0/6

What stands out

  • P/S below the industry

    American Vanguard's price-to-sales of 0.05 is below the Chemicals and Allied Products median of 3.39 (book value is negative, so we use sales).

  • Gross margin improving

    Gross margin was 28.4% over the last twelve months, against 24.1% a year earlier.

  • Short-term assets cover short-term debts

    Current assets are 2.02 times current liabilities.

What to watch

  • Revenue growing under 10% a year

    Revenue grew -5.5% a year over the last three fiscal years, short of the 10% we look for.

  • Interest not well covered

    Operating income covers interest expense -1.0 times; we look for at least 5.

  • Debt not well covered by cash flow

    Operating cash flow over the last twelve months equals -2.4% of total debt; we look for at least 20%.

  • Elevated bankruptcy risk

    The Altman Z-score is 1.30; above 3 is the safe zone and below 1.8 the distress zone.

Valuation1/6

  • P/E against its history

    Not enough price and earnings history to compare.

  • P/E against the industry

    Needs positive earnings and enough profitable companies in the industry.

  • EV/EBITDA against its history

    Needs positive EBITDA and price history.

  • P/S below the industry

    American Vanguard's price-to-sales of 0.05 is below the Chemicals and Allied Products median of 3.39 (book value is negative, so we use sales).

  • Price against fair value

    We could not estimate a fair value: it needs at least two valuation methods with positive inputs.

  • Margin of safety

    Depends on the fair value estimate.

Growth1/6

  • Revenue growing under 10% a year

    Revenue grew -5.5% a year over the last three fiscal years, short of the 10% we look for.

  • EPS growth over 3 years

    Needs positive EPS three years ago and today.

  • Earnings acceleration

    Needs positive net income now, a year ago and five years ago.

  • Growing slower than the industry

    Revenue grew -5.8% over the last twelve months; the Chemicals and Allied Products median is 3.5%.

  • Guidance issued

    The latest outlook (Full-Year Sales, Aug 11, 2026) was issued for the first time, so it neither adds nor takes away points.

  • Gross margin improving

    Gross margin was 28.4% over the last twelve months, against 24.1% a year earlier.

Past performance0/6

  • Return on equity

    Needs positive equity and five years of results.

  • Return on invested capital

    Needs operating income and invested capital.

  • Return on equity against the industry

    Needs positive equity.

  • Earnings over 5 years

    Needs positive net income five years ago and in the latest year.

  • Net margin below its 5-year average

    Net margin was -12.0% over the last twelve months, against a 5-year average of -4.7%.

  • Net margin below the industry

    American Vanguard's net margin of -12.0% is below the Chemicals and Allied Products median of -9.4%.

Financial health1/6

  • Debt level

    Needs debt and equity figures.

  • Debt trend

    Needs a balance sheet from five years ago with positive equity.

  • Debt not well covered by cash flow

    Operating cash flow over the last twelve months equals -2.4% of total debt; we look for at least 20%.

  • Interest not well covered

    Operating income covers interest expense -1.0 times; we look for at least 5.

  • Short-term assets cover short-term debts

    Current assets are 2.02 times current liabilities.

  • Elevated bankruptcy risk

    The Altman Z-score is 1.30; above 3 is the safe zone and below 1.8 the distress zone.

Dividend0/6

  • No dividend

    American Vanguard has not paid a dividend in the last twelve months.

  • Yield against Treasuries

    No dividend.

  • Yield against the market

    No dividend.

  • Dividend stability

    No dividend.

  • Earnings cover

    No dividend.

  • Cash-flow cover

    No dividend.

Scores of similar companies

Fair value

How we estimate it

We don't publish a fair value for American Vanguard. It needs a US-dollar share price, at least two valuation methods with positive inputs (earnings, EBITDA, book value or sales) and, for companies with several share classes, classes that trade at the same price.

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 26.4
  • Chemicals and Allied Products median 25.2

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

High risk

Average value traded per day
$616.78K
Value traded per 1% price move
$154.38K

Downside

High risk

Typical loss in a bad month
52.2%
Volatility (annualized)
73%
Sharpe ratio, 1 year
-1.20
Beta to the S&P 500 (5Y)
0.91

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2011 to 2025

Gross margin

28.6%−9.0 pts over 5 years

Operating margin

-5.5%−10.5 pts over 5 years

Net margin

-9.7%−13.0 pts over 5 years

See a number that looks wrong?